• First-in-human transplantation of chemically induced pluripotent stem-cell (CiPSC)-derived pancreatic islets was performed under the abdominal anterior rectus sheath in a type-1 diabetes patient, as reported in Cell (DOI: 10.1016/j.cell.2024.05.021).

• The procedure is framed as “growing a good tumor” at the front of the body, highlighting the experimental nature of situating endocrine tissue in a non-traditional anatomical site.

• A novel IP model is proposed: tokenize individual weights, neurons, or activation patterns inside running LLM instances so that owners can extract micro-rents on each prompt, creating a competitive market for “neuron ownership” rather than model ownership.

• Under this scheme, IP exclusivity would be confined solely to these instantiated neural assets; in exchange, all other domains of life (physical goods, labor, creative works) would be freed from traditional coercive IP claims.

• The conversation positions this as a potential grand bargain: technologists get monetizable AI IP while society gains freedom from broader intellectual-property restrictions.